Drug Trial Radar · NCT05312879
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
522
Actual
Start
Mar 30, 2022
Primary completion
Jun 2, 2028
Study completion May 7, 2030
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Apr 6, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney disease.
Conditions
- Proteinuric Kidney Disease
Interventions
VX-147Drug
Tablets for oral administration.
PlaceboDrug
Tablets for oral administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Percent Change From Baseline in Urine Protein to Creatinine Ratio (UPCR) at Week 48 (Assessed at the Week 48 Interim Analysis)Time frame: From Baseline to Week 48
- Part A: Estimated Glomerular Filtration Rate (eGFR) Slope Assessed at Interim AnalysisTime frame: From Baseline Through >= Week 48
- Part A: eGFR Slope Assessed at Final AnalysisTime frame: From Baseline Through Study Completion (At least 2 years of eGFR data assessed at the final analysis)
- Part B: Safety and Tolerability as Assessed by Number of Participants With Adverse events (AEs) and Serious Adverse Events (SAEs)Time frame: Day 1 Through Study Completion (Approximately 4 Years After the Last Participant Enrolls)
Locations
314 sites in 13 countries. Site status is shown where the registry gives one.
Alabama Kidney Research
Alabaster, Alabama
EmVenio Research - Mobile Unit - Birmingham
Birmingham, Alabama
Cardiology, P.C.
Birmingham, Alabama
Children's Hospital of Alabama
Birmingham, Alabama
The Kirklin Clinic - Nephrology
Birmingham, Alabama
Nephrology Associates
Fairhope, Alabama
Heart Center Research LLC
Huntsville, Alabama
Nephrology Consultants, LLC
Huntsville, Alabama
Renal Associates of Alabama, LLC
Montgomery, Alabama
Arizona Kidney Disease and Hypertension Center - Thomas Office
Phoenix, Arizona
Phoenix Children's Hospital, Inc. - Nephrology
Phoenix, Arizona
CHI St. Vincent Heart Clinic Arkansas- Cardiology and Medicine Clinic - Little Rock
Little Rock, Arkansas
UAMS Medical Center - Pulmonology
Little Rock, Arkansas
The Medical Research Group - Saint Agnes Medical Center
Fresno, California
Amicis Research Center - Balboa
Granada Hills, California
Kidney Care Center of North Valley
Granada Hills, California
Eastside Clinical Research Associates
Los Angeles, California
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California
Cedars-Sinai Medical Center
Los Angeles, California
UCLA Division of Nephrology
Los Angeles, California
UCI Center for Clinical Research
Orange, California
Kaiser Permanente Sacramento Medical Center
Sacramento, California
Helen Diller Medical Center at Parnassus Heights
San Francisco, California
UCLA Lundquist Institute at Harbor-UCLA Medical Center
Torrance, California
Kidney and Hypertension Center
Victorville, California
Greater Hartford Nephrology
Bloomfield, Connecticut
Nephrology & Hypertension Associates, PC
Middlebury, Connecticut
Yale University - Yale Nephrology Clinical Research Clinic
New Haven, Connecticut
Children's National Hospital - Nephrology
Washington D.C., District of Columbia
The George Washington University - GW Medical Faculty Associates
Washington D.C., District of Columbia
Veterans Affairs Medical Center - Washington D.C
Washington D.C., District of Columbia
Bay Pines Foundation
Bay Pines, Florida
Nova Clinical Research, LLC - Bradenton - 59th St
Bradenton, Florida
Clinical Research of Brandon, LLC
Brandon, Florida
AMR-Miami
Coral Gables, Florida
Horizon Research Group - Coral Gables
Coral Gables, Florida
South Florida Nephrology Research
Coral Springs, Florida
Delray Physician Care Center
Delray Beach, Florida
North Florida/South Georgia Veterans Health System
Gainesville, Florida
Shands Hospital - Nephrology
Gainesville, Florida
Showing 40 of 314 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.